MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/20406207211006022

Медицинская библиотека · Therapeutic advances in hematology · 2021

Safety and efficacy of a single total dose infusion (1020 mg) of ferumoxytol.

Khan Harris, May Paige, Kuo Elim, Pai Preetika, Boles Katherine, McGee Ashley, Dang Tanaka, Schmit Jessica

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: Iron deficiency anemia (IDA) is the most common type of anemia. A single dose infusion of intravenous (IV) iron is a convenient treatment option. Ferumoxytol is an IV formulation of iron that is typically given in two doses of 510 mg each. Utilizing a single dose of 1020 mg over 15 min has previously been described as safe and effective. In July 2018, we began to administer a single 1020 mg dose of ferumoxytol to patients needing IV iron replacement at the North Florida/South Georgia Veterans Health System. To evaluate the impact of this change, a utilization review was conducted.

METHODS

Outcomes of all patients who received ferumoxytol injections in the 6 months prior to and after the dosing strategy change were analyzed. A total of 140 patients, who received 270 separate IV ferumoxytol infusions, were included in the analysis.

RESULTS

No significant difference in safety was observed, with one infusion reaction occurring in each group (p = 1.00). Efficacy also appeared equivalent with no significant difference between the change in hemoglobin for those who received a single 1020 mg dose versus those who received two 510 mg doses (p = 0.764). As expected, those who received a single total dose infusion of 1020 mg had less clinic utilization (p < 0.0001).

CONCLUSION

In summary, ferumoxytol administered as a 1020 mg single dose infusion was more convenient and should be considered a safe and effective treatment option for IDA.

Для цитирования: Khan Harris, May Paige, Kuo Elim, Pai Preetika, Boles Katherine, McGee Ashley, Dang Tanaka, Schmit Jessica. Safety and efficacy of a single total dose infusion (1020 mg) of ferumoxytol.. Therapeutic advances in hematology. 2021. DOI: 10.1177/20406207211006022.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.